[go: up one dir, main page]

SK118798A3 - Pharmaceutically useful compounds - Google Patents

Pharmaceutically useful compounds Download PDF

Info

Publication number
SK118798A3
SK118798A3 SK1187-98A SK118798A SK118798A3 SK 118798 A3 SK118798 A3 SK 118798A3 SK 118798 A SK118798 A SK 118798A SK 118798 A3 SK118798 A3 SK 118798A3
Authority
SK
Slovakia
Prior art keywords
pyrazolo
hydroxy
formula
bond
methyl
Prior art date
Application number
SK1187-98A
Other languages
English (en)
Slovak (sk)
Inventor
John Bantick
Roger Bonnert
Peter Cage
David Donald
Mark Furber
Simon Hirst
Matthew Perry
Eifion Phillips
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605803.7A external-priority patent/GB9605803D0/en
Priority claimed from GBGB9610474.0A external-priority patent/GB9610474D0/en
Priority claimed from GBGB9610894.9A external-priority patent/GB9610894D0/en
Priority claimed from GBGB9700862.7A external-priority patent/GB9700862D0/en
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of SK118798A3 publication Critical patent/SK118798A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1187-98A 1996-03-20 1997-03-20 Pharmaceutically useful compounds SK118798A3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9605803.7A GB9605803D0 (en) 1996-03-20 1996-03-20 Pharmaceutically-active compound
GBGB9610474.0A GB9610474D0 (en) 1996-05-18 1996-05-18 Pharmaceutically active compounds
GBGB9610894.9A GB9610894D0 (en) 1996-05-24 1996-05-24 Pharmaceutically useful compounds
GBGB9700862.7A GB9700862D0 (en) 1997-01-16 1997-01-16 Pharmaceutically useful compounds
PCT/SE1997/000471 WO1997034893A1 (fr) 1996-03-20 1997-03-20 Composes pharmaceutiquement utiles

Publications (1)

Publication Number Publication Date
SK118798A3 true SK118798A3 (en) 1999-03-12

Family

ID=27451427

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1187-98A SK118798A3 (en) 1996-03-20 1997-03-20 Pharmaceutically useful compounds

Country Status (19)

Country Link
EP (1) EP0888347A1 (fr)
JP (1) JP2000506884A (fr)
KR (1) KR20000064716A (fr)
CN (1) CN1218472A (fr)
AR (1) AR006520A1 (fr)
AU (1) AU712141B2 (fr)
BR (1) BR9708103A (fr)
CA (1) CA2247814A1 (fr)
CZ (1) CZ297798A3 (fr)
EE (1) EE9800298A (fr)
ID (1) ID16283A (fr)
IL (1) IL126271A0 (fr)
IS (1) IS4848A (fr)
NO (1) NO984290L (fr)
NZ (1) NZ331614A (fr)
PL (1) PL328921A1 (fr)
SK (1) SK118798A3 (fr)
TR (1) TR199801861T2 (fr)
WO (1) WO1997034893A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110749A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
JP2003002863A (ja) * 2001-06-25 2003-01-08 Nippon Soda Co Ltd 安息香酸類の製造方法および新規化合物
US6642249B2 (en) 2001-07-04 2003-11-04 Active Biotech Ab Immunomodulating compounds
SE0102404D0 (sv) * 2001-07-04 2001-07-04 Active Biotech Ab Novel immunomodulating compounds
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
WO2004048378A1 (fr) * 2002-11-22 2004-06-10 Active Biotech Ab Pyrazoloquinolines a activite immunomodulatrice
WO2004055014A1 (fr) * 2002-12-16 2004-07-01 Active Biotech Ab Composes immunomodulateurs tetracycliques
ATE489388T1 (de) * 2003-03-14 2010-12-15 Medigene Ltd Immunmodulierende heterocyclische verbindungen
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
EP2284157A1 (fr) 2003-12-12 2011-02-16 Wyeth Quinolines utiles au traitement de maladies cardiovasculaires
FR2870239B1 (fr) * 2004-05-11 2006-06-16 Sanofi Synthelabo Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique.
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
PL1776366T3 (pl) 2004-08-09 2009-06-30 Medigene Ag Immunomodulujące oksopirazolocynoliny jako inhibitory CD80
ATE537151T1 (de) 2006-10-31 2011-12-15 Pfizer Prod Inc Pyrazolinverbindungen als mineralocorticoidrezeptorantagonisten
CN102372710A (zh) * 2010-08-18 2012-03-14 山东轩竹医药科技有限公司 作为盐皮质激素受体拮抗剂的并环类化合物
AU2012215741A1 (en) 2011-02-09 2013-08-22 Nissan Chemical Industries, Ltd. Pyrazole derivative and pest control agent
IL281212B2 (en) * 2018-09-07 2023-12-01 Merck Patent Gmbh 5-Morpholin-4-yl-pyrazolo[4,3-B]pyridine derivatives and their use
US11753413B2 (en) 2020-06-19 2023-09-12 Incyte Corporation Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
US11691971B2 (en) 2020-06-19 2023-07-04 Incyte Corporation Naphthyridinone compounds as JAK2 V617F inhibitors
WO2022006456A1 (fr) 2020-07-02 2022-01-06 Incyte Corporation Composés de pyridone tricyclique en tant qu'inhibiteurs de v617f de jak2
RS66978B1 (sr) 2020-07-02 2025-07-31 Incyte Corp Triciklična jedinjenja uree kao inhibitori jak2 v617f
US11661422B2 (en) 2020-08-27 2023-05-30 Incyte Corporation Tricyclic urea compounds as JAK2 V617F inhibitors
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
WO2022182839A1 (fr) 2021-02-25 2022-09-01 Incyte Corporation Lactames spirocycliques utilisés comme inhibiteurs du v617f de jak2
KR20240163688A (ko) 2022-03-17 2024-11-19 인사이트 코포레이션 Jak2 v617f 억제제로서의 삼환계 우레아 화합물
CN119638634A (zh) * 2023-09-18 2025-03-18 上海赛默罗生物科技有限公司 噌啉-2-氧化物类化合物及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524146A (en) * 1982-12-08 1985-06-18 Ciba-Geigy Corporation Certain -2-heterocycle substituted pyrazoloquinolines
JPS61112075A (ja) * 1984-11-05 1986-05-30 Shionogi & Co Ltd チエニルピラゾロキノリン誘導体
SE8903564D0 (sv) * 1989-10-26 1989-10-26 Pharmacia Ab New use condensed quinoline compound
JPH05194515A (ja) * 1991-07-31 1993-08-03 Kyowa Hakko Kogyo Co Ltd 縮合ナフチリジン誘導体

Also Published As

Publication number Publication date
NZ331614A (en) 2000-07-28
EE9800298A (et) 1999-02-15
KR20000064716A (ko) 2000-11-06
ID16283A (id) 1997-09-18
IS4848A (is) 1998-09-16
BR9708103A (pt) 1999-07-27
NO984290D0 (no) 1998-09-16
TR199801861T2 (xx) 1998-12-21
EP0888347A1 (fr) 1999-01-07
CA2247814A1 (fr) 1997-09-25
CN1218472A (zh) 1999-06-02
PL328921A1 (en) 1999-03-01
WO1997034893A1 (fr) 1997-09-25
AU712141B2 (en) 1999-10-28
JP2000506884A (ja) 2000-06-06
NO984290L (no) 1998-10-27
IL126271A0 (en) 1999-05-09
AR006520A1 (es) 1999-09-08
CZ297798A3 (cs) 1999-03-17
AU2186797A (en) 1997-10-10

Similar Documents

Publication Publication Date Title
SK118798A3 (en) Pharmaceutically useful compounds
ES2750236T3 (es) Derivados heteroaromáticos bicíclicos condensados como moduladores de la actividad del TNF
EP0738270B1 (fr) Dihydropyrazolopyrroles
RU2091374C1 (ru) Способ получения замещенных 5-арил-пиримидинов
US3995039A (en) Pyrazolo [1,5-a] [1,3,5] triazines
NZ207156A (en) (2 quinazolinyl)-oxalkylamide derivatives and pharmaceutical compositions
HUP0401537A2 (hu) Tiohidantoin-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására
WO2008104077A1 (fr) Inhibiteurs à petite molécule de protéines arginine méthyltransférases (prmt)
HU217623B (hu) Eljárás kondenzált tieno- és pirrolo [3,2-c]piridin-2-karbonsav-származékok valamint e vegyületeket tartalmazó gyógyászati készítmények előállítására
SK13712003A3 (en) Novel 4-anilinoquinoline-3-carboxamides
JP7174963B2 (ja) 疾患の処置のための複素環化合物
ES2260300T3 (es) Compuestos tetraciclicos sustituidos con amino utiles como agentes antiinflamatorios y composiciones farmaceuticas que comprenden los mismos.
WO2007129111A1 (fr) Dérivés de diazépine en tant qu'antagonistes de 5-ht2a
BR112016011844B1 (pt) Derivados de triazolpiridina como moduladores de atividade de tnf
JPH09301958A (ja) 新規ピリミジン化合物及び抗ロタウイルス剤
RU2109735C1 (ru) Оксопропаннитрильные производные конденсированного пиразола или их фармацевтически приемлемые соли, проявляющие иммуностимулирующую активность, и фармацевтическая композиция
CS274405B2 (en) Method of 4-cyanopyridazines preparation
US6395905B1 (en) Tetrahydroindazole derivatives as ligands for GABA-A α 5 receptors
WO2025139240A1 (fr) Inhibiteur de parp7 et son utilisation
PL128998B1 (en) Process for preparing novel 2-amino-3-benzoylphenylacetamides and their derivatives
IE55096B1 (en) 3-amino-6-aryl-1,2,4-triazolo(4,3-b)pyridazines,their preparation and their use
US5804685A (en) Deazapurine derivatives: a new class of CRF1 specific ligands
US20230257351A1 (en) Substituted n-phenylacetamides having p2x4 receptor antagonistic activity
JP3304086B2 (ja) 呼吸器官に対して抗炎症作用と抗喘息作用を有する[3H,7H]チアゾロ[3,4―a]ビリジン類
CA1262545A (fr) Imidazo-isoquinoleines et imidazothienopyridines